CN113116984A - Herbal formula for treating beriberi - Google Patents
Herbal formula for treating beriberi Download PDFInfo
- Publication number
- CN113116984A CN113116984A CN202110428520.2A CN202110428520A CN113116984A CN 113116984 A CN113116984 A CN 113116984A CN 202110428520 A CN202110428520 A CN 202110428520A CN 113116984 A CN113116984 A CN 113116984A
- Authority
- CN
- China
- Prior art keywords
- beriberi
- feet
- flower
- particles
- foot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/20—Fabaceae or Leguminosae [Pea or Legume family], e.g. pea, lentil, soybean, clover, acacia, honey locust, derris or millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Environmental Sciences (AREA)
- Botany (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a herbal formula for treating beriberi, and belongs to the field of Chinese herbal medicine preparations. 50-60 g of paulownia flower, 10-15 g of acacia flower and 10-15 g of green tea are mixed and crushed into particles, the particles are put into 3-3.5 l of water and are heated to 40-45 ℃ to soak feet for 30 minutes, the soaking time is once per day, the beriberi is cured after the soaking time is two weeks of continuous use, and the medicine has obvious curative effect on patients with severe beriberi. The invention has the advantages of convenient material acquisition, low cost, rich resources, no toxicity or side effect, mild drug effect and no irritation, and has the effects of clearing away heat and toxic materials and dispelling wind and heat. Clinical data show that the cure rate of beriberi can reach more than 95.2 percent, and the treatment effect is good.
Description
Technical Field
The invention relates to a herbal formula for treating beriberi, and belongs to the field of Chinese herbal medicine preparations.
Background
The beriberi is a common disease in life of people, and is known as tinea pedis, which is a foot dermatosis caused by pathogenic fungi. Because the sebaceous glands are not arranged between the sole plate and the toes of the foot of the human, the fatty acid for inhibiting the skin filamentous fungi is lacking, so the physiological defense function of the foot of the human is poor, the skin sweat glands of the parts are rich, the sweating is more, the air circulation is poor, and the local humidity and the warmth are beneficial to the growth of the filamentous fungi. In addition, the cuticle of the skin of the sole plate is thick, and keratin in the cuticle is rich in nutrients of fungi and is beneficial to the growth of the fungi. Beriberi is highly contagious and, in fact, the vast majority of patients are caused by infection. Especially during peak periods of outbreaks in summer.
In severe beriberi, the feet are full of blisters which break, and the blisters can also emit unpleasant odor, especially in the spaces between toes, and the ulceration is more serious. Once beriberi is attacked, patients often feel itching and have hard to endure, erythema and desquamation appear between toes, and the whole soles of patients with serious symptoms turn red and peel. The beriberi not only seriously affects the daily work and life of the patient, but also is very easy to infect other people.
At present, a plurality of medicines for treating beriberi in the market are mainly divided into a traditional Chinese medicine type and a western medicine type. The traditional Chinese medicine type medicines mainly adopt medicinal materials with the effects of resisting bacteria and diminishing inflammation and promoting blood circulation to remove blood stasis, have small side effect, but have slow curative effect, and patients cannot always adhere to long-term treatment; some medicines have quick curative effect but are easy to repeat, and after a plurality of treatments, the curative effect is gradually reduced because of drug resistance of fungi. In western medicines, antifungal medicines such as pyrrole, polyene and echinocandin are selected frequently, and the effects are obvious when the antifungal medicines are used for the first time, but the beriberi is recurrent because fungi are remained on shoes and socks, and the like, and the fungi generate drug resistance when the antifungal medicines are used for the later period, so that the curative effect is gradually reduced.
At present, the medicines sold in pharmacy for treating beriberi mainly comprise Zuguansan, beriberi ointment and the like, but most of the medicines are prepared by blending chemical reagents and are not good for human health. Therefore, it is necessary to develop a pure Chinese medicinal powder for treating beriberi.
The inventor always focuses on the research of beriberi in the first generations, and finally summarizes and obtains a very effective herbal formula for treating beriberi through researching hundreds of herbaceous plants with the effects of killing viruses, killing bacteria, relieving itching and the like and thousands of tests and searches clinically. The pain and the trouble of the beriberi patient are solved by the formula.
Disclosure of Invention
In order to overcome the defects or shortcomings in the prior art, the invention provides an herbal formula for treating beriberi, which is characterized by comprising the following raw materials in parts by weight: 50 to 60 grams of paulownia flower, 10 to 15 grams of acacia flower and 10 to 15 grams of green tea.
Further, 50-60 g of paulownia flower, 10-15 g of acacia flower and 10-15 g of green tea are crushed into particles with the diameter of 1-5 mm, then the particles are uniformly mixed, the mixture is put into 3-3.5L of water, and the mixture is heated to 40-45 ℃ and soaked in both feet for 30 minutes, once a day and continuously used for two weeks.
Further, after the patient has soaked the foot, the footwear worn by the patient is immersed in the mixed solution after soaking the foot, and the mixed solution together with the footwear is heated to 60 ℃ +/-5 ℃ and kept for 10 minutes. Therefore, germs on the shoes and the socks can be effectively killed, and the feet can be prevented from being infected again by the residual germs on the shoes and the socks.
The pharmacology of the invention is as follows:
paulownia flower: contains ethers and alcohols, and can be used for treating inflammation, viral infection, tinea manus, tinea pedis, skin ulcer, furuncle, burn, etc., and has inhibitory effect on Staphylococcus aureus and Bacillus subtilis.
Acacia flower: the product is rich in rutin, sophocarpiol and saccharides, and has effects of preventing inflammation, resisting fungi, and enhancing immunity.
Green tea leaf: has good sterilizing and disinfecting effects.
Compared with the prior art, the herbal formula for treating beriberi provided by the invention has the following beneficial effects:
1) the raw materials are convenient to obtain, the cost is low, the resources are rich, and the storage is convenient;
2) all the raw materials are pure natural Chinese herbal medicines, so that the traditional Chinese medicine is non-toxic and free of side effect, mild in drug effect and free of irritation;
3) traditional Chinese medicine considers that the dermatophytosis is mainly caused by wind-heat damp evil, particularly, the damp evil invades into the body and is stagnated in the body of a human body, the damp-heat evil cannot be timely eliminated from the body by normal disease-resistant factors of the human body, the damp-heat evil still remains in the qi and blood, and the qi and blood run in four limbs of the human body to bring the damp-heat evil into the local part to cause the disease. The composition has the effects of clearing away heat and toxic materials and dispelling wind and heat, can quickly open foot acupuncture points of a human body and activate meridians and blood when being used in a heating state by being matched with water, can discharge damp toxin and heat evil in the human body, can quickly improve the drug effect, and fully exerts the drug effect. Can solve the problem of poor curative effect of the traditional Chinese medicine preparation on dermatophytosis in the prior art.
Detailed Description
The herbal formula for treating beriberi of the invention is further described by combining specific examples, which mainly comprise the following raw materials in parts by weight: 50 to 60 grams of paulownia flower, 10 to 15 grams of acacia flower and 10 to 15 grams of green tea. The using method comprises the following steps: 50-60 g of paulownia flower, 10-15 g of acacia flower and 10-15 g of green tea are crushed into particles with the diameter of 1-5 mm, then the particles are uniformly mixed, put into 3-3.5 l of water and heated to 40-45 ℃ to be soaked in feet for 30 minutes, and the soaking is carried out once a day and is continuously used for two weeks.
Preferably, after the patient has soaked the foot, the footwear worn by the patient is immersed in the mixed liquid after soaking the foot, and the mixed liquid and the footwear are heated to 60 +/-5 ℃ and kept for 10 minutes. Therefore, germs on the shoes and the socks can be effectively killed, and the feet can be prevented from being infected again by the residual germs on the shoes and the socks.
Clinical trial
Test subjects: the total number of the patients with beriberi is 147, and the patients are divided into mild, moderate and severe according to the degree of the beriberi, wherein the mild patients are 43, the moderate patients are 48 and the severe patients are 56.
The test method comprises the following steps: the application method for treating the beriberi provided by the embodiment is used for treating the beriberi, and the dosage of the medicine is once a day for two weeks.
The evaluation standard of curative effect is as follows:
and (3) healing: the beriberi completely disappears, and the medication is not continued.
The method has the following advantages: the beriberi is obviously improved and needs to be treated continuously.
And (4) invalidation: the beriberi is not improved, and other medicines are needed for treatment.
The test results are shown in the following table.
Name (R) | The number of healed people | Number of effective persons | Number of invalid persons | Toxic and side effects |
Mild patients | 42 | 1 | 0 | 0 |
Moderate patients | 46 | 2 | 0 | 0 |
Severe patient | 52 | 3 | 1 | 0 |
As can be seen from clinical test data, the treatment method is actually used on 147 patients, the number of completely cured patients reaches 140, the cure rate reaches 95.2%, the number of invalid patients is only 1, the failure rate is only 0.68%, and the treatment effect is good.
The specific cases of several cured patients are selected and explained as follows:
old men and 36 years old have 4 years of beriberi, and the beriberi is serious sweaty feet, blisters exist among toes, erosion exists among toes, the feet are often difficult to endure with pruritus, the feet are often scratched to see blood, and the feet emit pungent odor. The treatment starts in 2 months of 2020, after the foot is soaked by the foot lotion provided by the invention on the first day, the feet feel fresh and cool in the evening like being coated with talcum powder, and on the second day, the feet do not have odor any more, so that after the foot lotion is continuously used for one week, the itching symptom of the feet disappears, the water bubbles disappear, and the feet recover to be healthy. The treatment is continued for 5 days, and no relapse occurs until the follow-up is reached.
Li Shi, male, 37 years old, suffered from beriberi for 5 years, had blisters between toes, had erosion between toes, and had frequent itching and intolerance of feet, and often both feet were scratched to see blood. The ointment is usually applied on the plaster for treating beriberi, the application is improved, the relapse of the ointment is stopped, and the ointment can not be cured radically after repeated treatment. The medicine starts to be used for treatment in 4 months in 2020, after the medicine is used for soaking feet in the medicine on the first day, the feet have a refreshing feeling, and after the medicine is continuously used for 5 days, the water bubbles disappear, the pruritus is obviously relieved, the erosion face is healed, the medicine is continuously used for one week, the symptoms are completely eliminated, the medicine is continuously used for 5 days, and the disease does not relapse until the follow-up visit.
In Song Dynasty, male, age 43, suffered from beriberi for four years, had red and swollen foot ulcer, which reached 1/2, mainly had small blister ulcer, itching, pain and local fever, and was treated repeatedly, and infected repeatedly. The treatment starts in 2018 and 9 months, after the feet are soaked in the foot bath liquid, the feet are soaked and wiped to be dry on the first day, the feet feel clear and cool obviously and do not emit odor any more, the itching is relieved after the foot bath liquid is continuously used for one week, new healthy skin starts to sprout on the festered surface, after the foot bath liquid is used for one week, the itching symptom disappears, the water bubbles disappear, and the feet are recovered to be healthy. The treatment is continued for 5 days, and no relapse occurs until the follow-up is reached.
The beriberi is infected by certain song daughter in the age of 17 years, namely certain song daughter in the age of 17 years, and is 1 year old, because the beriberi is usually treated by purchasing commercially available beriberi medicaments during the period, the feet are not ulcerated, and only a small amount of small blisters are accompanied by pruritus symptoms. After the treatment of the foot bath lotion starts in 11 months in 2018, the first day is that both feet do not have odor, and after the foot bath lotion is continuously used for a week, pruritus symptoms disappear, blisters disappear, and the feet are recovered to be healthy. The treatment is continued for 5 days, and no relapse occurs until the follow-up is reached.
The above description is only an example of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by using the contents of the present specification and embodiments, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (3)
1. The herbal formula for treating beriberi is characterized by comprising the following raw materials in parts by weight: 50 to 60 grams of paulownia flower, 10 to 15 grams of acacia flower and 10 to 15 grams of green tea.
2. The herbal formula for treating beriberi as claimed in claim 1, wherein 50-60 g paulownia flower, 10-15 g acacia flower and 10-15 g green tea are crushed into particles with the diameter of 1-5 mm, then the particles are uniformly mixed, placed into 3-3.5 l of water and heated to 40-45 ℃ to soak feet for 30 minutes, once a day, and continuously used for two weeks.
3. A herbal formulation for the treatment of tinea pedis as claimed in claim 1 or 2, wherein after the patient has soaked his foot, the footwear worn by the patient is immersed in the mixed solution after soaking his foot, and the mixed solution together with the footwear is heated to 60 ℃ ± 5 ℃ for 10 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110428520.2A CN113116984A (en) | 2021-04-21 | 2021-04-21 | Herbal formula for treating beriberi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110428520.2A CN113116984A (en) | 2021-04-21 | 2021-04-21 | Herbal formula for treating beriberi |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113116984A true CN113116984A (en) | 2021-07-16 |
Family
ID=76778804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110428520.2A Withdrawn CN113116984A (en) | 2021-04-21 | 2021-04-21 | Herbal formula for treating beriberi |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113116984A (en) |
-
2021
- 2021-04-21 CN CN202110428520.2A patent/CN113116984A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
CN104096047A (en) | Externally-applied detoxification ointment for treatment of poisonous snake bite wound and preparation method thereof | |
CN104857290A (en) | Traditional Chinese medicine disinfection ointment for treating scalds and burns and preparation method thereof | |
CN1052420C (en) | Chinese medicine for curing burn and traumatic wound and its production method | |
CN103446240B (en) | Traditional Chinese medicine composition for rapidly healing wounds | |
CN105560620A (en) | Trauma treatment traditional Chinese medicine preparation | |
US20090263500A1 (en) | Composition and method for treating bedsores, cuts and burns | |
CN113116984A (en) | Herbal formula for treating beriberi | |
CN102579656A (en) | Medicinal composition for treating tinea pedis | |
CN104257777B (en) | Traditional Chinese medicine composition for treating rhinitis, nasosinusitis and frontal sinusitis and preparation method of traditional Chinese medicine composition | |
CN104306707A (en) | Medicament composition for treating bedsore | |
CN108186683A (en) | A kind of Chinese medicine composition for treating psoriasis and preparation method thereof | |
CN104306734B (en) | Treat diabetic gangrene externally applied ointment preparation and preparation method thereof | |
CN108355130A (en) | It is a kind of to treat psoriasic temperature sensitive type collagen composite antiphlogistic gel spray and preparation method thereof | |
CN108635362A (en) | A kind of pharmaceutical composition for treating diabetes | |
CN113633717B (en) | Electronic atomized liquid composition for nasal cavity care, application thereof and obtained care product | |
CN102552362A (en) | Medicament for treating tinea | |
CN1615967A (en) | Chinese herbal medicine for treating beri-beri | |
KR20080083847A (en) | The manufacturing and using method of treatment for skin trouble | |
CN114377100A (en) | Biological plant foot soaking liquid | |
CN114288345A (en) | Medicine for treating burn and scald and its preparing method | |
CN113975343A (en) | High-efficiency sterilization and bacteriostasis traditional Chinese medicine spray | |
CN117281854A (en) | Scar soft powder and its preparation method | |
CN103768226A (en) | Traditional Chinese medicinal composition for treating tinea manus and tinea pedis and preparation method thereof | |
CN1180554A (en) | External use ointment for skin health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210716 |
|
WW01 | Invention patent application withdrawn after publication |